雷蛇捐赠5,000个外科口罩予香港弱势社群
雷蛇(01337.HK)公布,透过本港线上医疗初创企业iMeddy捐赠5,000个外科口罩予香港弱势社群。雷蛇已调整部分生产线以生产口罩,并从其他渠道采购口罩进行捐赠,以缓解全球的口罩短缺问题,首批运送到港的5,000个口罩将全数通过iMeddy及本地非牟利机构博爱堂服务中心所合办的「众筹口罩送基层」众筹活动,分配到弱势社群。
於4月初,公司亦决定连同跨国房地产企业星狮地产(Frasers Property)、亚洲共享办公空间品牌JustCo Global以及机器与工业解决方案供应商PBA集团於新加坡设立自动化口罩生产线,以协助东南亚国家对抗疫情。所有口罩均於新加坡制造,符合国际标准,预计每月可生产数百万个获认证口罩。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.